Cargando…

Respiratory infections regulated blood cells IFN‐β‐PD‐L1 pathway in pediatric asthma

BACKGROUND: Respiratory infections, in general, and rhinovirus infection specifically are the main reason for asthma exacerbation in children and programmed cell death protein 1 ligand (PD‐L1) expression inhibits T cell responses. OBJECTIVE: Could the interferon (IFN) type I expression in peripheral...

Descripción completa

Detalles Bibliográficos
Autores principales: Kölle, Julia, Haag, Patricia, Vuorinen, Tytti, Alexander, Kiefer, Rauh, Manfred, Zimmermann, Theodor, Papadopoulos, Nikolaos G., Finotto, Susetta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7416032/
https://www.ncbi.nlm.nih.gov/pubmed/32394602
http://dx.doi.org/10.1002/iid3.307
Descripción
Sumario:BACKGROUND: Respiratory infections, in general, and rhinovirus infection specifically are the main reason for asthma exacerbation in children and programmed cell death protein 1 ligand (PD‐L1) expression inhibits T cell responses. OBJECTIVE: Could the interferon (IFN) type I expression in peripheral blood mononuclear cells (PBMCs) improve disease exacerbation in pediatric asthma? RESULTS: Here we found increased level of PD‐L1 messenger RNA (mRNA) in total blood cells isolated from preschool children with virus‐induced asthma, with lower percentage of forced expiratory volume in 1 second and with high serum levels of the C‐reactive‐protein. CONCLUSIONS AND CLINICAL RELEVANCE: These data indicate that, in the presence of infection in the airways of preschool children, worse asthma is associated with induced PD‐L1 mRNA expression in blood cells. Further, type I IFN, IFN‐β, a cytokine that is involved in the clearance of infections, was found to be associated with a better lung function in asthmatic children. These data suggest that improving peripheral blood IFN type I expression in PBMCs in pediatric asthma could improve disease exacerbation due to suppressing PD‐L1 expression in blood cells.